Real-time enrollment status for this hereditary hemorrhagic telangiectasia (hht) clinical trial
Current Status
Recruiting
Checked: October 5, 2026 at 11:53 PM UTC
| NCT Number | NCT07601425 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Hemorrhagic Telangiectasia (HHT) |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Atavistik Bio, Inc |
| Last Updated on CT.gov | October 5, 2026 (23 hours ago) |
As of October 5, 2026: Clinical trial NCT07601425 is currently recruiting participants. This phase1 study for hereditary hemorrhagic telangiectasia (hht) is actively seeking new participants at 6 locations across the United States. The study is sponsored by Atavistik Bio, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07601425 is actively recruiting participants as of October 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07601425 was last updated 23 hours ago (October 5, 2026). HelloStudys verifies this status automatically.